1: Pushie MJ, Nienaber KH, Summers KL, Cotelesage JJ, Ponomarenko O, Nichol HK, Pickering IJ, George GN. The solution structure of the copper clioquinol complex. J Inorg Biochem. 2014 Apr;133:50-6. doi: 10.1016/j.jinorgbio.2014.01.003. Epub 2014 Jan 16. PubMed PMID: 24503514.
2: Kawamura K, Kuroda Y, Sogo M, Fujimoto M, Inui T, Mitsui T. Superoxide dismutase as a target of clioquinol-induced neurotoxicity. Biochem Biophys Res Commun. 2014 Sep 12;452(1):181-5. doi: 10.1016/j.bbrc.2014.04.067. Epub 2014 Apr 19. PubMed PMID: 24755073.
3: Katsuyama M, Ibi M, Matsumoto M, Iwata K, Ohshima Y, Yabe-Nishimura C. Clioquinol increases the expression of VGF, a neuropeptide precursor, through induction of c-Fos expression. J Pharmacol Sci. 2014;124(4):427-32. Epub 2014 Mar 19. PubMed PMID: 24646654.
4: Yildiz T, Ilce Z, Yildirim M, Akdogan M, Yurumez Y, Varlikli O, Dilek FH. Antienflamatuar and antiadhesive effect of clioquinol. Int J Surg. 2015 Mar;15:17-22. doi: 10.1016/j.ijsu.2015.01.022. Epub 2015 Jan 29. PubMed PMID: 25638731.
5: Wang Z, Wang Y, Li W, Mao F, Sun Y, Huang L, Li X. Design, synthesis, and evaluation of multitarget-directed selenium-containing clioquinol derivatives for the treatment of Alzheimer's disease. ACS Chem Neurosci. 2014 Oct 15;5(10):952-62. doi: 10.1021/cn500119g. Epub 2014 Aug 22. PubMed PMID: 25121395.
6: Rodríguez-Santiago L, Alí-Torres J, Vidossich P, Sodupe M. Coordination properties of a metal chelator clioquinol to Zn(2+) studied by static DFT and ab initio molecular dynamics. Phys Chem Chem Phys. 2015 May 28;17(20):13582-9. doi: 10.1039/c5cp01615k. PubMed PMID: 25939963.
7: Chan-On W, Huyen NT, Songtawee N, Suwanjang W, Prachayasittikul S, Prachayasittikul V. Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells. Drug Des Devel Ther. 2015 Apr 8;9:2033-47. doi: 10.2147/DDDT.S79313. eCollection 2015. PubMed PMID: 25897210; PubMed Central PMCID: PMC4396583.
8: Bareggi SR, Cornelli U. Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther. 2012 Jan;18(1):41-6. doi: 10.1111/j.1755-5949.2010.00231.x. Epub 2010 Dec 27. Review. PubMed PMID: 21199452.
9: Oyama TM, Ishida S, Okano Y, Seo H, Oyama Y. Clioquinol-induced increase and decrease in the intracellular Zn2+ level in rat thymocytes. Life Sci. 2012 Dec 10;91(23-24):1216-20. doi: 10.1016/j.lfs.2012.09.014. Epub 2012 Oct 5. PubMed PMID: 23044228.
10: Mao F, Yan J, Li J, Jia X, Miao H, Sun Y, Huang L, Li X. New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol. Org Biomol Chem. 2014 Aug 21;12(31):5936-44. doi: 10.1039/c4ob00998c. PubMed PMID: 24986600.
11: Abdel-Aleem EA, Hegazy MA, Sayed NW, Abdelkawy M, Abdelfatah RM. Novel spectrophotometric determination of flumethasone pivalate and clioquinol in their binary mixture and pharmaceutical formulation. Spectrochim Acta A Mol Biomol Spectrosc. 2015 Feb 5;136 Pt B:707-13. doi: 10.1016/j.saa.2014.09.085. Epub 2014 Sep 30. PubMed PMID: 25448970.
12: Geiser J, De Lisle RC, Finkelstein D, Adlard PA, Bush AI, Andrews GK. Clioquinol synergistically augments rescue by zinc supplementation in a mouse model of acrodermatitis enteropathica. PLoS One. 2013 Aug 28;8(8):e72543. doi: 10.1371/journal.pone.0072543. eCollection 2013. PubMed PMID: 24015258; PubMed Central PMCID: PMC3755987.
13: Wang Z, Wang Y, Wang B, Li W, Huang L, Li X. Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer's Disease. J Med Chem. 2015 Nov 12;58(21):8616-37. doi: 10.1021/acs.jmedchem.5b01222. Epub 2015 Oct 27. PubMed PMID: 26473791.
14: Schimmer AD, Jitkova Y, Gronda M, Wang Z, Brandwein J, Chen C, Gupta V, Schuh A, Yee K, Chen J, Ackloo S, Booth T, Keays S, Minden MD. A phase I study of the metal ionophore clioquinol in patients with advanced hematologic malignancies. Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):330-6. doi: 10.1016/j.clml.2012.05.005. Epub 2012 Jun 9. PubMed PMID: 22683301.
15: Zheng J, Benbrook DM, Yu H, Ding WQ. Clioquinol suppresses cyclin D1 gene expression through transcriptional and post-transcriptional mechanisms. Anticancer Res. 2011 Sep;31(9):2739-47. PubMed PMID: 21868515.
16: Kharadi GJ. Effect of substituent of terpyridines on the in vitro antioxidant, antitubercular, biocidal and fluorescence studies of copper(II) complexes with clioquinol. Spectrochim Acta A Mol Biomol Spectrosc. 2014 Jan 3;117:662-8. doi: 10.1016/j.saa.2013.09.049. Epub 2013 Sep 28. PubMed PMID: 24128919.
17: Ghalkhani M, Fernandes IP, Oliveira SC, Shahrokhian S, Oliveira-Brett AM. Anodic behavior of clioquinol at a glassy carbon electrode. Bioelectrochemistry. 2011 Feb;80(2):175-81. doi: 10.1016/j.bioelechem.2010.10.001. Epub 2010 Oct 16. PubMed PMID: 21111689.
18: Finkelstein DI, Hare DJ, Billings JL, Sedjahtera A, Nurjono M, Arthofer E, George S, Culvenor JG, Bush AI, Adlard PA. Clioquinol Improves Cognitive, Motor Function, and Microanatomy of the Alpha-Synuclein hA53T Transgenic Mice. ACS Chem Neurosci. 2016 Jan 20;7(1):119-29. doi: 10.1021/acschemneuro.5b00253. Epub 2015 Oct 30. PubMed PMID: 26481462.
19: Cater MA, Haupt Y. Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer. Biochem J. 2011 Jun 1;436(2):481-91. doi: 10.1042/BJ20110123. Erratum in: Biochem J. 2011 Aug 1;437(3):575. PubMed PMID: 21426304.
20: Mussani F, Poon D, Skotnicki-Grant S. Systemic contact dermatitis to topical clioquinol/hydrocortisone combination cream. Dermatitis. 2013 Jul-Aug;24(4):196-7. doi: 10.1097/DER.0b013e3182910430. PubMed PMID: 23857012.